Prostate Cancer Specification
0.1.0 - ci-build

Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Gesicherte Prostatakarzinom-Diagnose nach Biopsie - JSON Representation

Raw json | Download

{
  "resourceType" : "Condition",
  "id" : "CoreNeedleBiopsyDiagnosisConfirmed",
  "meta" : {
    "profile" : [
      🔗 "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-diagnose-primaertumor|2026.0.0"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Condition CoreNeedleBiopsyDiagnosisConfirmed</b></p><a name=\"CoreNeedleBiopsyDiagnosisConfirmed\"> </a><a name=\"hcCoreNeedleBiopsyDiagnosisConfirmed\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.onkologie@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-diagnose-primaertumor\">MII PR Onkologie Diagnose Primärtumor</a> version: 2026.0.0</p></div><p><b>Condition Asserted Date</b>: 2024-01-17</p><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}\">Confirmed</span></p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-category encounter-diagnosis}\">Encounter Diagnosis</span></p><p><b>code</b>: <span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/icd-10-gm C61}, {http://snomed.info/sct 126906006}, {http://id.who.int/icd/release/10 C61}, {http://id.who.int/icd/release/11/mms 2C82}\">Bösartige Neubildung der Prostata</span></p><p><b>subject</b>: <a href=\"Patient-Patient1.html\">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</a></p><p><b>encounter</b>: <a href=\"Encounter-CoreNeedleBiopsyEncounter.html\">Encounter: identifier = http://example.hospital.de/encounters#E_24_001; status = finished; class = IMB (IMB)</a></p><p><b>onset</b>: 2024-01-17</p><p><b>recordedDate</b>: 2024-01-17</p><h3>Stages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Summary</b></td><td><b>Type</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 1222766008}\">IIA (AJCC)</span></td><td><span title=\"Codes:{http://snomed.info/sct 260998006}\">Clinical staging (qualifier value)</span></td></tr></table><p><b>note</b>: </p><blockquote><div><p>Prostatakarzinom mit ISUP Grade Group 2-3, multifokal in 6 von 12 Stanzen nachgewiesen. Klinisches Stadium cT2a cN0 cM0. Intermediäres Risiko nach D'Amico.</p>\n</div></blockquote></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/condition-assertedDate",
      "valueDateTime" : "2024-01-17"
    }
  ],
  "clinicalStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
        "code" : "active"
      }
    ]
  },
  "verificationStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/condition-ver-status",
        "code" : "confirmed"
      }
    ]
  },
  "category" : [
    {
      "coding" : [
        {
          "system" : "http://terminology.hl7.org/CodeSystem/condition-category",
          "code" : "encounter-diagnosis"
        }
      ]
    }
  ],
  "code" : {
    "coding" : [
      {
        "system" : "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
        "version" : "2026",
        "code" : "C61",
        "display" : "Bösartige Neubildung der Prostata"
      },
      {
        "system" : "http://snomed.info/sct",
        "code" : "126906006",
        "display" : "Neoplasm of prostate (disorder)"
      },
      {
        "system" : "http://id.who.int/icd/release/10",
        "code" : "C61",
        "display" : "Malignant neoplasm of prostate"
      },
      {
        "system" : "http://id.who.int/icd/release/11/mms",
        "code" : "2C82",
        "display" : "Malignant neoplasms of prostate"
      }
    ]
  },
  "subject" : {
    🔗 "reference" : "Patient/Patient1"
  },
  "encounter" : {
    🔗 "reference" : "Encounter/CoreNeedleBiopsyEncounter"
  },
  "onsetDateTime" : "2024-01-17",
  "recordedDate" : "2024-01-17",
  "stage" : [
    {
      "summary" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "1222766008",
            "display" : "IIA (AJCC)"
          }
        ]
      },
      "type" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "260998006",
            "display" : "Clinical staging (qualifier value)"
          }
        ]
      }
    }
  ],
  "note" : [
    {
      "text" : "Prostatakarzinom mit ISUP Grade Group 2-3, multifokal in 6 von 12 Stanzen nachgewiesen. Klinisches Stadium cT2a cN0 cM0. Intermediäres Risiko nach D'Amico."
    }
  ]
}